The current valuation score of WAVE Life Sciences Ltd is 8.33, ranking 108 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.23, which is -66.64% below the recent high of -1.74 and -525.61% above the recent low of -32.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.